These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20515261)

  • 1. Design, in vitro and in vivo evaluation of glipizide Eudragit microparticles.
    Madhusudhan S; Panda AK; Parimalakrishnan S; Manavalan R; Manna PK
    J Microencapsul; 2010; 27(4):281-91. PubMed ID: 20515261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evaluation of membrane-moderated transdermal system of glipizide.
    Mutalik S; Udupa N
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):17-26. PubMed ID: 16445694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and properties of sustained-release pellets of glycyrrhizin effective components].
    Chen LH; Feng Y; Xu DS; Li JS; Zhang L; Wang YH
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):509-13. PubMed ID: 18536370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
    Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
    Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
    Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and statistical optimization of glipizide loaded lipospheres using response surface methodology.
    Shivakumar HN; Patel PB; Desai BG; Ashok P; Arulmozhi S
    Acta Pharm; 2007 Sep; 57(3):269-85. PubMed ID: 17878108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
    Maghsoodi M; Esfahani M
    Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
    Krishnamachari Y; Madan P; Lin S
    Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
    Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
    Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
    Katara R; Majumdar DK
    Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glipizide matrix transdermal systems for diabetes mellitus: preparation, in vitro and preclinical studies.
    Mutalik S; Udupa N; Kumar S; Agarwal S; Subramanian G; Ranjith AK
    Life Sci; 2006 Sep; 79(16):1568-77. PubMed ID: 16730752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring of locust bean gum and development of hydrogel beads for controlled oral delivery of glipizide.
    Maiti S; Dey P; Banik A; Sa B; Ray S; Kaity S
    Drug Deliv; 2010 Jul; 17(5):288-300. PubMed ID: 20350054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA; Basit AW
    Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: in vitro/in vivo evaluation.
    Barakat NS; Almurshedi AS
    J Microencapsul; 2011; 28(2):122-33. PubMed ID: 21110773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique.
    Kibria G; Ul-Jalil R
    Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: preparation and characterization.
    Venugopalan P; Sapre A; Venkatesan N; Vyas SP
    Pharmazie; 2001 Mar; 56(3):217-9. PubMed ID: 11265586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, Optimization and In vitro Evaluation of Glipizide Nanoparticles Integrated with Eudragit RS-100.
    Saharan P; Bahmani K; Saharan SP
    Pharm Nanotechnol; 2019; 7(1):72-85. PubMed ID: 30892168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.